Blood Flow Restriction Training for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if reducing blood flow during specific strengthening exercises can improve symptoms in people with Parkinson's disease. The study will test two groups: one will perform exercises with blood flow restriction, while the other will do the exercises without it. Ideal participants are those diagnosed with Parkinson's disease who experience significant balance issues. As an unphased study, this trial allows participants to contribute to innovative research that could lead to new therapeutic strategies for Parkinson's disease.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that blood flow restriction training and instability resistance training are safe for Parkinson's disease patients?
Research has shown that blood flow restriction (BFR) training is generally safe for people with Parkinson's disease. Studies have found it can improve movement and reduce symptoms without major safety concerns. Minor risks include a small chance of muscle damage (1.9%) and fainting (3.8%), but these are rare. Overall, BFR training appears to be a promising and well-tolerated exercise option.12345
Why are researchers excited about this trial?
Researchers are excited about blood flow restriction (BFR) training for Parkinson's disease because it offers a new approach to managing symptoms. Unlike traditional treatments like medication and physical therapy, which primarily aim to manage symptoms and improve mobility over time, BFR training combines low-intensity exercise with restricted blood flow to enhance muscle strength and endurance more efficiently. This method could potentially allow for similar benefits to high-intensity workouts but with less strain on the body, which is particularly beneficial for individuals with Parkinson's. Additionally, when paired with instability resistance training (IRT), there’s potential for even greater improvements in balance and coordination, addressing key challenges faced by those with Parkinson's disease.
What evidence suggests that this trial's treatments could be effective for Parkinson's disease?
Research has shown that blood flow restriction (BFR) training can improve strength and muscle function in individuals with neurological conditions like Parkinson's disease. In this trial, participants in the BFR plus Instability Resistance Training group will receive a combination of these therapies. One study found that BFR training improved movement and reduced symptoms such as restless legs. Another study suggested that BFR might be more effective than high-intensity training for enhancing heart and blood vessel health in those with Parkinson's. Reviews indicate that BFR offers benefits in both the short and medium term, making it a promising option for boosting strength and balance. Overall, BFR training appears to be a safe and effective way to help manage Parkinson's symptoms.15678
Who Is on the Research Team?
Anjali Sivaramakrishnan, PhD, PT
Principal Investigator
The University of Texas Health Science Center at San Antonio
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants will receive either Blood Flow Restriction plus Instability Resistance Training or Instability Resistance Training only, with 2 sessions per week over 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of balance, mobility, and muscle strength
What Are the Treatments Tested in This Trial?
Interventions
- Blood flow restriction training
- Instability Resistance Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center at San Antonio
Lead Sponsor
National Institute on Aging (NIA)
Collaborator